Patent · US Active

Method for treating melanoma

US10144772B2 · kind B2 · utility

0Cited by
0References
12Claims
0Family size

Assignees

Inventors

Key dates

Filing dateMay 12, 2015
Grant dateDec 4, 2018
Priority date
Expiry dateMay 12, 2035

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2333/70539
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to a TNFα blocking agent for use in the treatment and prevention of melanoma in a subject in whom melanoma cells express MHCI and in whom stroma cells exhibit TNF expression.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.